[1] |
Uchiyama K,Ueno M,Ozawa S. Risk factors for postoperative infectious complications after hepatectomy. J Hepatobiliary Pancreat Sci, 2011, 18(1): 67-73.
|
[2] |
中华人民共和国卫生部(卫办医政发[2011]121号).原发性肝癌诊疗规范(2011年版).临床肿瘤学杂志, 2011, 16(10): 929-946.
|
[3] |
汤钊猷.肝癌临床研究的展望.中国现代普通外科进展, 2009, 12(4): 277-278.
|
[4] |
Llovet JM,Ricci S,Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med, 2008, 359(4): 378-390.
|
[5] |
Cheng AL,Kang YK,Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase Ⅲ randomised, double-blind, placebo-controlled trial. Lancet Oncol, 2009, 10(1): 25-34.
|
[6] |
Gustafson JD,Fox JP,Ouellette JR, et al. Open versus laparoscopic liver resection: looking beyond the immediate postoperative period. Surg Endosc, 2012, 26(2): 468-472.
|
[7] |
Viganò L,Tayar C,Laurent A, et al. Laparoscopic liver resection: a systematic review. J Hepatobiliary Pancreat Surg, 2009, 16(4): 410-421.
|
[8] |
Zhou Y,Sui C,Li B, et al. Repeat hepatectomy for recurrent hepatocellular carcinoma: a local experience and a systematic review. World J Surg Oncol, 2010, 8: 55-65.
|
[9] |
Wu CC,Cheng SB,Yeh DC, et al. Second and third hepatectomies for recurrent hepatocellular carcinoma are justified. Br J Surg, 2009, 96(9): 1049-1057.
|
[10] |
樊嘉,王征.原发性肝癌的手术切除.中华外科杂志, 2010, 48(3): 167-168.
|
[11] |
吕毅,张谞丰.肝细胞肝癌的多学科协作组概念及其实践[J/CD].中华肝脏外科手术学电子杂志, 2013, 2(1): 1-3.
|
[12] |
Okabayashi T,Iyoki M,Sugimoto T, et al. Oral supplementation with carbohydrate- and branched-chain amino acid-enriched nutrients improves postoperative quality of life in patients undergoing hepatic resection. Amino Acids, 2011, 40(4): 1213-1220.
|
[13] |
黎介寿.肠内营养——外科临床营养支持的首选途径.中国实用外科杂志, 2003, 10(3): 67.
|
[14] |
王新颖,牛程麟,章黎,等.肠内营养对肝功能障碍患者腹部手术后肝功能及炎性反应的改善.中华胃肠外科杂志, 2011, 14(5): 336-339.
|
[15] |
秦环龙,杨俊.外科手术后肠内营养的时机、途径和制剂选择.中国实用外科杂志, 2008, 28(1): 79-80.
|
[16] |
黎介寿.临床营养支持的发展趋势.肠外与肠内营养, 2010, 17(1): 1-4.
|
[17] |
韦军民.欧美外科营养指南解读.中国实用外科杂志, 2012, 32(2): 107-109.
|